Organization
Xinjiang Medical University
1 clinical trial
1 abstract
Clinical trial
Clinical Characteristics and Outcomes of Coronary Heart Disease: a Prospective Cohort StudyStatus: Completed, Estimated PCD: 2022-01-31
Abstract
Effectiveness and safety of camrelizumab in advanced esophageal cancer: A prospective multicenter observational cohort studies (ESCORT-RWS).Org: Peking University Cancer Hospital and Institute (Beijing Cancer Hospital), Beijing, China, Beijing InnoCare Pharma Tech, China National Biotec Group, Changzhi People's Hospital Affiliated to Changzhi Medical College, Changzhi City,